Stock listing
NASDAQ:ADRO Aduro Biotech Inc Stock
Follow Aduro Biotech Inc into a list and get an email when it puts out news.
Delisted NASDAQ:ADRO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ADRO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Aduro Biotech Inc on 6ix
- Decks
- 9 decks · latest Jun 12, 2023
Where Aduro Biotech Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ADRO · This page · Delisted | NASDAQ | United States | USD |
| NASDAQ:KDNY · Delisted | NASDAQ | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Chinook Therapeutics — Technical Presentation (June 2023) | Technical | 6 slides | Jun 12, 2023 |
| Merger or Acquisition (June 2020) | Merger or acquisition | 14 slides | Jun 2, 2020 |
| Jefferies Virtual Healthcare Conference 2020 | Conference | 18 slides | Jun 2, 2020 |
| Merger or Acquisition (June 2020) | Merger or acquisition | 16 slides | Jun 2, 2020 |
| Investor Presentation (January 2020) | Investor deck | 40 slides | Jan 13, 2020 |
| Investor Presentation (January 2019) | Investor deck | 30 slides | Jan 7, 2019 |
| Investor Presentation (January 2018) | Investor deck | 35 slides | Jan 8, 2018 |
| J.P. Morgan Healthcare Conference 2017 | Conference | 31 slides | Jan 9, 2017 |
| Investor Presentation (January 2016) | Investor deck | 39 slides | Jan 11, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Azelby Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past) | Director · Apr 10, 2023 – Aug 11, 2023 · Past |
| Srinivas Akkaraju Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Mar 18, 2025); Alumis Inc. (Founder and Managing Member, Samsara BioCapital · Since at least Jun 27, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 23, 2024); Mineralys Therapeutics, Inc. (Board Member · Since at least Feb 9, 2023); Scholar Rock Holding Corporation (Director · Since at least Jul 26, 2022); Jiya Acquisition Corp (Director · Sep 23, 2022 – Sep 23, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 1, 2022 – Sep 16, 2024 · Past); Intercept Pharmaceuticals Inc (Director · May 25, 2022 – Nov 8, 2023 · Past) | Director · May 26, 2022 – Aug 11, 2023 · Past |
| Eric Dobmeier Other companies: Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Janux Therapeutics, Inc. (Director · Since at least Jul 19, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Atara Biotherapeutics, Inc. (Director · Jun 27, 2019 – Nov 10, 2023 · Past); Adaptive Biotechnologies Corporation (Director · Jun 26, 2019 – Feb 14, 2021 · Past) | President, CEO, Director · Oct 5, 2020 – Aug 11, 2023 · Past |
| Jennifer Lew Other companies: Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Annexon, Inc. (EVP & CHIEF FINANCIAL OFFICER · Since at least Jul 23, 2020); Dynavax Technologies Corporation (VP, Finance & PAO · Jan 31, 2012 – Feb 5, 2013 · Past) | Chief Financial Officer · Apr 14, 2015 – May 1, 2019 · Past |
| Natalie Sacks Other companies: Caribou Biosciences, Inc. (Partner at Novo Holdings Ventures Investment · Since at least Jul 22, 2021); Harpoon Therapeutics Inc (Chief Medical Officer · Feb 7, 2019 – Jan 28, 2022 · Past); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past) | Chief Medical Officer · Aug 31, 2016 – Sep 12, 2018 · Past |
| James H Welch Other companies: Eiger Biopharmaceuticals Inc (Chief Financial Officer · Mar 22, 2016 – Mar 14, 2018 · Past); Talphera, Inc. (Chief Financial Officer · Feb 10, 2011 – Feb 4, 2014 · Past) | See Remarks · Jul 15, 2019 – Jul 15, 2019 · Past |
| Michelle Griffin Other companies: Adaptive Biotechnologies Corporation (Board Member · Since at least Mar 6, 2023); Acer Therapeutics Inc (Director · Mar 14, 2023 – Mar 14, 2023 · Past) | Director · May 26, 2022 – Aug 11, 2023 · Past |
| Andrew King Other companies: Jade Biosciences, Inc. (President, Research & Development · Since at least Apr 28, 2025) | Chief Scientific Officer · Oct 5, 2020 – Aug 11, 2023 · Past |
| Andrew Oxtoby Other companies: Kalaris Therapeutics, Inc. (CEO & Director · Since at least Mar 18, 2025) | Chief Commercial Officer · Feb 15, 2023 – Aug 11, 2023 · Past |
| Dirk G Brockstedt Other companies: RAPT Therapeutics Inc (CHIEF SCIENTIFIC OFFICER · Since at least Oct 30, 2019) | EVP of Research and Dev. · Oct 2, 2017 – Dec 29, 2017 · Past |
All 14 people
| Person | Seat |
|---|---|
| Thomas W Dubensky Other companies: Tempest Therapeutics, Inc. (President, Director · Jun 25, 2021 – Jan 3, 2023 · Past) | Chief Scientific Officer · Apr 14, 2015 – Aug 10, 2017 · Past |
| Tom Frohlich Other companies: Jade Biosciences, Inc. (Chief Executive Officer, Director · Since at least Apr 28, 2025) | Chief Operating Officer · Oct 5, 2020 – Aug 11, 2023 · Past |
| William G Kachioff Other companies: Eiger Biopharmaceuticals Inc (CFO · Apr 12, 2023 – Apr 12, 2023 · Past) | Interim CFO · Jan 22, 2020 – Jun 1, 2020 · Past |
| Celeste Ferber | SVP, GC and Secretary · May 20, 2019 – Sep 15, 2020 · Past |
Log in to ask 6ix AI your own questions about Aduro Biotech Inc.